Showing results (151-160 of 319) with videos related to
Sort By:
Pageof 32
Retrovirology|August 9, 2008
Natural variation of HIV-1 group M integrase: implications for a new class of antiretroviral inhibitorsSoo-Yon Rhee, Tommy F Liu, Mark Kiuchi, et al.AIDS (London, England)|July 17, 2007
Virologic efficacy of boosted double versus boosted single protease inhibitor therapyMaya L Petersen, Yue Wang, Mark J van der Laan, et al.The Review of Scientific Instruments|April 29, 2026
High-speed fiber-optic bolometry enabled by deconvolution signal processingXiaoli Wang, Babak Moeinimaleki, Ayush Chinmay, et al.AIDS (London, England)|March 22, 2008
Sequence editing by Apolipoprotein B RNA-editing catalytic component [corrected] and epidemiological surveillance of transmitted HIV-1 drug resistanceRobert J Gifford, Soo-Yon Rhee, Nicolas Eriksson, et al.Nucleic Acids Research|January 24, 2018
Diff-seq: A high throughput sequencing-based mismatch detection assay for DNA variant enrichment and discoveryDimitra Aggeli, Vlad O Karas, Nicholas A Sinnott-Armstrong, et al.AIDS (London, England)|January 2, 2007
HIV-1 protease and reverse transcriptase mutations for drug resistance surveillanceRobert W Shafer, Soo-Yon Rhee, Deenan Pillay, et al.Plos Computational Biology|April 26, 2008
Viral population estimation using pyrosequencingNicholas Eriksson, Lior Pachter, Yumi Mitsuya, et al.Annals of Internal Medicine|December 28, 1999
HIV-1 genotypic resistance patterns predict response to saquinavir-ritonavir therapy in patients in whom previous protease inhibitor therapy had failedA R Zolopa, R W Shafer, A Warford, et al.Plos One|April 25, 2013
In vitro HIV-1 evolution in response to triple reverse transcriptase inhibitors & in silico phenotypic analysisBarbara A Rath, Kaveh Pouran Yousef, David K Katzenstein, et al.BMC Bioinformatics|December 17, 2011
A multifaceted analysis of HIV-1 protease multidrug resistance phenotypesKathleen M Doherty, Priyanka Nakka, Bracken M King, et al.Pageof 32